ClinicalTrials.gg
RecruitingNCT07470437Updated Jul 27, 2026

The Mouth Matters in Mental Health Trial -2

An interventional study of Link work intervention in Mental Health, Oral Health Care and Psychosis, sponsored by Lancashire and South Cumbria NHS Foundation Trust. Recruiting at 5 sites in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-27.

Primary conditionPsychotic DisordersRegistry: Psychological Well-BeingReclassifiedWhy we changed it
Registry
Psychological Well-Being — the first condition term the registry derived for this study.
ClinicalTrials.gg
Psychotic Disorders
Why
  1. Psychological Well-Being is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Psychotic Disorders.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Lancashire and South Cumbria NHS Foundation Trust · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started May 2026; still recruiting 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
480
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 75 studies in Psychotic Disorders with a site in United Kingdom — 19 open to participants now, 22 under way, 4 of them phase 3. Psychotic Disorders · United Kingdom.

Planned enrollment
6th of 60
480 · median 59
Started
2026
with 6 others
No phase
37 of 75
9 open now
Primary completion
2029-07
later than 18 of 21 live
Registered
72nd of 75
by date

Among the 75 studies in Psychotic Disorders with a site in United Kingdom, this one is the 6th largest by planned enrollment of the 60 interventional ones that give a count, is one of 7 that started in 2026, is one of 37 with no phase, reaches primary completion later than 18 of the 21 other live ones, and was the 72nd registered.

Psychotic Disorders

1,593 studies on the registry are indexed under Psychotic Disorders; 283 are open to participants now.

Browse Psychotic Disorders studies →

Open to participants now

19 of the 75 studies in Psychotic Disorders with a site in United Kingdom are open now. Recruiting first, the newest first:

13 more — sign in →

All 19 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 204 Psychotic Disorders studies recruiting now, 53 (26%) set no upper age limit and 142 (70%) stop at 75 or younger; 50 take children under 18; 41 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 75 studies in Psychotic Disorders with a site in United Kingdom, or all of them as a file.
02

Study summary

This clinical trial will evaluate the effectiveness and cost-effectiveness of a link work intervention for supporting people with severe mental health difficulties to attend a routine dental appointment. There are two main outcomes, namely: i) attendance at a routine dental appointment; and ii) oral health quality of life.

The main predictions are that:

  1. The link work intervention plus treatment as usual will lead to greater likelihood of attendance at a routine dental appointment, compared with treatment as usual alone.
  2. The link work intervention plus treatment as usual will lead to better oral health quality of life, compared with treatment as usual alone.
  3. The link work intervention plus treatment as usual will be cost-effective compared with treatment as usual alone.
Read the detailed description

Aim: To evaluate the effectiveness and cost-effectiveness of a link work intervention to facilitate dental attendance in people with severe mental illness.

Methods: An effectiveness randomised-controlled trial with integrated cost-effectiveness analysis and process evaluation. 480 participants will be recruited from five NHS Trusts and randomised (ratio 1:1) to either treatment as usual or treatment as usual plus the link work intervention. The link work intervention will follow the manual co-developed and used in the feasibility trial. Blind research assistants will support participants to complete assessments at baseline and after nine-months. The investigators will obtain consent to access participant's dental visiting data via the Business Services Authority. The primary outcomes are i) attendance at a routine dental appointment, and ii) oral health related quality of life. Health economics analysis will assess whether the intervention is cost-effective. A qualitative process evaluation will help to understand how it works and might be implemented.

Results/conclusions: This research hopes to produce the first evidenced-based intervention for improving the oral health of people with severe mental illness. It could help to overcome inequities in dental access.

03

Conditions studied

  • Mental Health
  • Oral Health Care
  • Psychosis

Browse trials for

Keywords

  • Mouth Matters
  • Dentistry
  • mental health
04

In context

Psychotic Disorders Reclassified

1,593 studies on the registry are indexed under Psychotic Disorders; 283 are open to participants now.

This study's planned enrollment of 480 is above the median of 65 across 1,326 interventional studies indexed under Psychotic Disorders.

Browse Psychotic Disorders studies →

Lead sponsor

This is the only study on the registry with Lancashire and South Cumbria NHS Foundation Trust as lead sponsor.

Compared within Psychotic Disorders, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Psychological Well-Being. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged ≥18 years.
  • Receipt of care from community mental health or early intervention teams at the point of referral.
  • No routine dental appointment (e.g. high street dentist, special care dentist service) in the past three years. This would include any dental examination, diagnosis, advice or treatment (e.g. fillings, root canal, extractions, crowns, dentures, bridges) resulting from a routine (non-emergency) appointment at a dental service. Emergency dental care (e.g. emergency attendance at an Accident \& Emergency Appointment or a dental hospital) is not included within this definition, although any follow-up routine and planned appointments with a dentist would exclude the person from taking part.
  • Able to provide as determined by trained researchers in consultation with the clinical team.

Exclusion criteria

Exclusion Criteria:

  • Current inpatient status on psychiatric ward. This does not include people in rehabilitation homes or supported accommodation in the community.
  • Immediate risk to self or others operationalised as the presence of active intent or planning to harm oneself or others in the near future (e.g. next month), or a suicide attempt in the past month (e.g. life-threatening self-harm, overdose). Where individuals are excluded on this basis, with the person's consent, the researcher will aim to re-contact them and/or the referrer in approximately one-months' time to determine if risk has subsided to a point where they are now eligible.
  • Enrolled in another dental randomised controlled trial.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

06

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
480 participants (estimated)

Study arms

  • No intervention
    Treatment as usual

    Treatment as usual will include any treatments or services that the participant would normally have access to outside of the trial. For people with severe mental illness this may include support from a care coordinator, support worker, psychologist, occupational therapist, and/or psychiatrist for care around their mental health. Treatment as usual may include medication and case management. The investigators will monitor, rather than withhold, assessment and treatment for oral health in the treatment as usual arm.

  • Experimental
    Treatment as usual plus a link work intervention

    Participants in this arm will receive treatment as usual plus the link work intervention. This will consist of six sessions with a link worker over nine-months who will offer practical and emotional support around accessing a routine dental appointment.

    Behavioral: Link work intervention

Interventions

  • BehavioralLink work intervention

    The mental health link work intervention uses link workers to empower and assist people with severe mental illness currently supported by secondary care mental health services, but not dental services, to access planned dental appointments. The link work intervention in the study proposal has the following dimensions: * Delivered by mental health support workers. * Focused on oral health as the primary health issue. * Setting is in secondary mental health care linking to dental care * Primary role is navigating or bridging services. * It builds motivation where needed and offers advocacy. * Its builds self-efficacy and recursively through social persuasion, positive reinforcement, and positive experiences of dental visits and interacting with dental services. * Training and supervision to link workers supports intervention delivery.

07

What researchers measure

Primary outcomes

  1. Attendance at a planned care appointments

    As measured by the National Health Services Business Services Authority (NHS BSA).

    Time frame: From baseline to nine-month follow-up assessment.

  2. Oral health related quality of life

    Oral Health Impact Profile - 14 item version (OHIP-14), range: 0-56, higher scores indicate worse oral health related quality of life

    Time frame: From baseline to nine-month follow-up assessment .

Secondary outcomes

  1. Self-reported attendance at a planned dental appointment.

    Self-report dental attendance items.

    Time frame: From baseline to nine-month follow-up assessment.

  2. Orofacial pain & disability

    Manchester Orofacial Pain Disability Scale. Two binary outcomes plus scale. Range: 0-52. Higher scores indicates greater pain (binary) / help seeking (binary) / pain related disability (scale).

    Time frame: From baseline to nine-month follow-up assessment

  3. Confidence around dental visiting

    Single item of self-efficacy around attendance. Range 1-7. A higher score indicates greater confidence around dental visiting.

    Time frame: From baseline to nine-month follow-up assessment.

  4. Self-esteem

    Rosenberg Self-Esteem Scale. Range: 0-30. A higher score indicates better self-esteem.

    Time frame: From baseline to nine-month follow-up assessment

  5. Dental anxiety

    Modified Dental Anxiety Scale. Range: 5-25. A higher score indicates greater levels of dental anxiety.

    Time frame: From baseline to nine-month follow-up assessment.

  6. General anxiety

    Generalised Anxiety Disorder Questionnaire. Range: 0-21. A higher score indicates greater levels of anxiety.

    Time frame: From baseline to nine-month follow-up assessment .

  7. Depression

    Patient Health Questionnaire - 9 items. Range 0-27. A higher score indicates greater levels of depression.

    Time frame: From baseline to nine-month follow-up assessment.

  8. The number of planned dental appointments attended

    Recorded via the National Health Service Business Services Authority.

    Time frame: From baseline to nine-month follow-up assessment.

  9. Self-reported access to free/subsidised dental care.

    Self-report items

    Time frame: From baseline to nine-month follow-up assessment.

  10. Exemption status for dental care

    As recorded by the National Health Service Business Services Authority

    Time frame: From baseline to nine-month follow-up assessment.

  11. Completion of a course of dental treatment

    As record via the National Health Service Business Services Authority.

    Time frame: From baseline to nine-month follow-up assessment.

  12. Self-reported utilisation of urgent or emergency dental services.

    Self-report items

    Time frame: From baseline to nine-month follow-up assessment.

  13. Quality adjusted life years

    European Quality of Life five-dimensional questionnaire (EQ-5D-5L). Five health dimensions plus overall health score on a visual analogue scale range. Range on visual analogue scale: 0-100. A higher score indicates better health.

    Time frame: From baseline to nine-month follow-up assessment.

  14. Utilization of healthcare resources

    Co-designed health economics questionnaire recording utilisation of services and treatment.

    Time frame: From baseline to nine-month follow-up

08

Study locations

4 of 5 sites recruiting
09

References and documents

Individual participant data

Plan to share: Yes — Following publication of the trial results, the investigators will make suitable arrangements for anonymised data to be available from the research team, in line with NIHR data sharing guidance. This will be outlined in the Data Access Management Plan (DAMP) developed in the early phases of the project.

Supporting information: Study protocol, Statistical analysis plan

Time frame: Exact plans and timescales will be developed during the early phases of the project and outlined within a Data Access Management Plan (DAMP). The IPD will only be available from the point of the results being published and after 31/07/2029.

Access criteria: Exact specifications around who can apply for access to anonymized data and how will be outlined in the Data Access Management Plan (DAMP). Key considerations will include the confidentiality and privacy of participants; respect to the terms of consent by individuals who are involved in research; consistency with relevant legal, ethical and regulatory frameworks; and guarding against unreasonable costs.

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for Jul 2029, 38 months after the start.

Of 460 non-industry interventional studies with no phase under Psychotic Disorders, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 52. This study's planned 38 months is above that.

Counting every sponsor, half of 462 studies reached it within 34 months; a quarter within 19 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 10, 2026
First posted
Mar 13, 2026
StartActual
May 1, 2026
Primary completionEst.
Jul 31, 2029
CompletionEst.
Jul 31, 2029
Last update
Jul 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT07470437
Lead sponsor
Lancashire and South Cumbria NHS Foundation Trust
Collaborators
Greater Manchester Mental Health NHS Foundation Trust, Pennine Care NHS Foundation Trust, Northumberland, Tyne and Wear NHS Foundation Trust, South London and Maudsley NHS Foundation Trust, Lancaster University, University of Liverpool, University of Leeds, University of Manchester, King's College London
Responsible party
Jasper Palmier-Claus (Chief Investigator; Senior Lecturer; Principal Clinical Psychologist, Lancaster University) — Principal investigator
First posted
Mar 13, 2026
Start date
May 1, 2026
Primary completion
Jul 31, 2029 (estimated)
Completion
Jul 31, 2029 (estimated)
Last update
Jul 27, 2026

Study contacts

Dr Palmier-Claus, PhD, DClinPsy
Contact
J.Palmier-Claus@lancaster.ac.uk
+44 1772 773500

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion